The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Saakian S.V.

Moscow Helmholtz Research Institute of Eye Diseases, Moscow, Russia

Amirian A.G.

FGBU "Moskovskiĭ NII glaznykh bolezneĭ im. Gel'mgol'tsa" Minzdrava Rossii

Tsygankov A.Iu.

FGBU "Moskovskiĭ NII glaznykh bolezneĭ im. Gel'mgol'tsa" Minzdrava Rossii

Loginov V.I.

Institute of General Pathology and Pathophysiology, 8 Baltiiskaya St., Moscow, Russian Federation, 125315

Burdennyy A.M.

Institute of General Pathology and Pathophysiology, 8 Baltiiskaya St., Moscow, Russian Federation, 125315

Association of the ABCB1 gene with risk for uveal melanoma

Authors:

Saakian S.V., Amirian A.G., Tsygankov A.Iu., Loginov V.I., Burdennyy A.M.

More about the authors

Read: 1072 times


To cite this article:

Saakian SV, Amirian AG, Tsygankov AIu, Loginov VI, Burdennyy AM. Association of the ABCB1 gene with risk for uveal melanoma. Russian Journal of Archive of Pathology. 2014;76(2):3‑7. (In Russ.)

Recommended articles:

References:

  1. Brovkina A.F. Oftal'moonkologiya [Ophthalmooncology]. Manual for physicians . Moscow: Meditsina Publ.; 2002. 424 p.
  2. Zaletaev D.V, Nemtsova M.V, Babenko O.V. System of genetic and epigenetic markers in the DNA- diagnosis of malignant neoplasms. In: Pal'tsev M.A., ed. Vvedenie v molekulyarnuyu meditsinu. [Introduction to molecular medicine] Moscow: Meditsina Publ.; 2009: 35-93. (In Russ.)
  3. Saakyan S.V., Brovkina A.F. Tumors of the choroid. In: Brovkina A.F., ed. Oftal'moonkologiya [Ophthalmooncology]. Guide for physicians. Moscow: Meditsina Publ.; 2002: 235-298. (In Russ.)
  4. Sychev D.A., Ignat'ev I.V., Ramenskaya G.V., Kolkhir S.V., Kukes V.G. Value of gene MDR1 polymorphism, encoding a glycoprotein-P for individualization of pharmacotherapy. Klinicheskaya farmakologiya i terapiya. 2005; 14 (1): 92-96. (In Russ.)
  5. Boldt H.C. Posterior segment tumors: the latest in current management. Retina. 2006; 26 (6, Suppl.): S37-44.
  6. Finger P.T. The 7th edition AJCC staging system for eye cancer: an international language for ophthalmic oncology. Arch. Pathol. Lab. Med. 2009; 133: 1197-8.
  7. Kim R.B., Leake B.F., Choo E.F. et al. Identification of functionally variant MDR1 alleles among European Americans and African Americans. Clin. Pharmacol. Ther. 2001; 70 (2): 189-99.
  8. Landreville S., Agapova O.A., Kneass Z.T., Salesse C., Harbour J.W. ABCB1 identifies a subpopulation of uveal melanoma cells with high metastatic propensity. Pigment Cell Melanoma Res. 2011; 24 (3): 430-7.
  9. Laver N.V., McLaughlin M.E., Duker J.S. Ocular melanoma. Arch Pathol Lab Med. 2010; 134 (12): 1778-84.
  10. Marzolini C., Paus E., Buclin T., Kim R.B. Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance. Clin. Pharmacol. Ther 2004; 75 (1): 13-33.
  11. Onken M.D., Ehlers J.P., Worley L.A., Makita J., Yokota Y., Harbour J.W. Functional gene expression analysis uncovers phenotypic switch in aggressive uveal melanomas. Cancer Res. 2006; 66: 4602-9.
  12. Onken M.D., Worley L.A., Tuscan M.D., Harbour J.W. An accurate, clinically feasible multi-gene expression assay for predicting metastasis in uveal melanoma. J. Mol. Diagn. 2010; 12: 461-8.
  13. Scholes A.G., Damato B.E., Nunn J., Hiscott P., Grierson I., Field J.K. Monosomy 3 in uveal melanoma: correlation with clinical and histological predictors of survival. Invest. Ophthalmol. Vis. Sci. 2003; 44 (3): 1008-11.
  14. Schuster R., Bechrakis N.E., Stroux A. et al. Circulating tumor cells as prognostic factor for distant metastases and survival in patients with primary uveal melanoma. Clin. Cancer Res. 2007; 13 (4): 1171-8.
  15. Shields C.L. The hunts for the secrets of uveal melanoma. Clin. Exp. Ophthalmol. 2008; 36 (3): 277-80.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.